Status | Study |
Recruiting |
Study Name: TAB08 in Patients With Systemic Lupus Erythematosus (SLE), Not Adequately Controlled With Current Treatment Condition: Lupus Erythematosus, Systemic Date: 2016-03-14 Interventions: Drug: TAB08 biologic |
Completed |
Study Name: MSC2364447C Phase 1b in Systemic Lupus Erythematosus Condition: Lupus Erythematosus, Systemic Date: 2015-08-28 Interventions: Drug: MSC2364447C Subjects wil |
Active, not recruiting |
Study Name: A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus Condition: Lupus Erythematosus, Systemic Date: 2015-07-17 Interventions: Drug: IPP-201101 Other Name: L |
Active, not recruiting |
Study Name: A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus Condition: Lupus Erythematosus, Systemic Date: 2015-04-29 Interventions: Biological: ALX-0061 Biological: Placebo |
Active, not recruiting |
Study Name: A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus Condition: Lupus Erythematosus, Systemic Date: 2015-01-23 Interventions: Drug: Ustekinumab IV Weight-ra |
Active, not recruiting |
Study Name: Exploratory Study of MT-1303 in Systemic Lupus Erythematosus Patients Condition: Systemic Lupus Erythematosus Date: 2014-11-18 Interventions: Drug: MT-1303 Low dose Drug: MT-1303 High |
Completed |
Study Name: Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus Condition: Lupus Erythematosus, Systemic Date: 2013-10-24 Interventions: Drug: Atacicept 75 milligram (mg) |
Enrolling by invitation |
Study Name: An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults Condition: Lupus Erythematosus, Systemic Date: 2012-12-17 Interventions: Biological: MEDI-546 MEDI-546, IV q4wks for 104 weeks |
Suspended |
Study Name: Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine Condition: Systemic Lupus Erythematosus Date: 2008-10-17 Interventions: Drug: N-acetylcysteine Capsule |
Completed |
Study Name: Study Evaluating The SBI-087 In Subjects With Systemic Lupus Erythematosus Condition: Lupus Erythematosus, Systemic Date: 2008-07-08 Interventions: Drug: SBI-087 Single IV or SC dose of SBI-087 |